Interacting Drugs |
Doxepin (topical) vs Lumefantrine |
Security Level |
 |
Mechanism |
Lumefantrine: May enhance the QTc-prolonging effect of QTc-Prolonging Agents. |
Management |
Avoid combination |
Doxepin (topical) vs Lumefantrine
Post Review about Doxepin (topical) vs Lumefantrine Click here to cancel reply.
Other Interactions of Doxepin (topical)
Other Interactions of Lumefantrine
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.